Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus.

Hsin-Wen ChangYa-Wen LinMing-Hung LinYu-Ching LanRuey-Yun Wang

Published in: PloS one (2019)

Gout patients with prolonged ULT and a high dose of ULT were associated with a significant increase in T2DM risk. Although gout patients with age greater than 50 years and a lower dose of ULT may be beneficial in lowering T2DM risk, further clinical studies need to be confirmed these associations.

Keyphrases

high dose
low dose
uric acid
stem cells
type diabetes
metabolic syndrome
mesenchymal stem cells
stem cell transplantation
bone marrow
glycemic control